Avrin Pharma is an independent UK-based Site Management Organization (SMO) dedicated to the planning, management, and execution of Phase 2-4 clinical trials across a broad spectrum of therapeutic areas. Our mission is to advance medical science by delivering ethical, efficient, and patient-focused research that improves outcomes for patients worldwide.
We partner with leading CROs, sponsors, and healthcare professionals to ensure that every study is conducted with the highest standards of quality, safety, and compliance. Our experienced team supports all aspects of clinical research, from patient recruitment, site selection, and operational management to data integrity, monitoring, and regulatory adherence, ensuring trials progress smoothly and efficiently.
Our therapeutic focus areas include Metabolic & Cardiovascular Diseases, Neurology, Infectious Diseases, and Immunology, allowing us to bring specialized knowledge and proven expertise to each study. We pride ourselves on building collaborative partnerships with investigators and sites, emphasizing rapid study start-up, robust patient engagement, and streamlined operational processes.
At Avrin Pharma, we are committed to Good Clinical Practice (GCP), MHRA guidelines, and global ethical standards, ensuring the highest level of care for patients while maintaining data integrity and regulatory compliance. We leverage advanced operational strategies and cutting-edge technologies to maximize efficiency, improve trial outcomes, and accelerate scientific discovery.
By combining scientific rigor, operational excellence, and patient-centered care, Avrin Pharma is shaping the future of evidence-based medicine. We invite CROs, sponsors, healthcare professionals, and patients to partner with us and join in advancing clinical research that drives meaningful health outcomes globally.

🌐 Website: www.avrinpharma.com
📧 Email: info@avrinpharma.com
🔗 Follow us for updates on ongoing trials, partnerships, and research insights.

Avrin Pharma

Org chart

Teams

Offices